So they’re starting their own. A group of major American hospitals, battered by price spikes on old drugs and long-lasting shortages of critical medicines, has launched a mission-driven, not-for-profit generic drug company, Civica Rx, to take some control over the drug supply

Quick Read

Julia Brody writes, “My lab has been doing that for years.”

Quick Read

Frustrated with the slow transition towards open access (OA) in scientific publishing, 11 national funding organizations in Europe turned up the pressure today. As of 2020, the group, which jointly spends around €7.6 billion on research annually, will require every paper it funds to be freely available from the moment of publication

Quick Read

Diabetic ketoacidosis is a terrible way to die. It’s what happens when you don’t have enough insulin. Your blood sugar gets so high that your blood becomes highly acidic, your cells dehydrate, and your body stops functioning

Quick Read

Want to Live Longer?

August 31, 2018

Consider the ethics. Life extension – using science to slow or halt human aging so that people live far longer than they do naturally – may one day be possible

Quick Read

Lost in the Storm

August 31, 2018

Houston thought it was prepared for a major hurricane like Harvey. But as the flooding overwhelmed the city’s emergency systems, families like the Daileys found out too late that they were on their own

Quick Read

A cutting-edge CAR-T cell therapy for otherwise untreatable forms of blood cancer is too expensive to justify its use on Britain’s state-funded health service, the country’s healthcare cost agency NICE said on Tuesday

Quick Read

In fact, the study suggests that the Medicaid expansion may be a tool in the fight against the opioid crisis. With comments from study coauthor, our Brendan Saloner

Quick Read